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Abstract 25 
 26 
Iota toxin is a binary toxin solely produced by Clostridium perfringens type E strains, and 27 
is structurally related to CDT from C. difficile and CST from C. spiroforme. As type E 28 
causes hemorrhagic enteritis in cattle, it is usually assumed that associated diseases are 29 
mediated by iota toxin, although evidence in this regard has not been provided. In the 30 
present report, iota toxin intestinal effects were evaluated in vivo using a mouse model. 31 
Histological damage was observed in ileal loops treated with purified iota toxin after 4 h of 32 
incubation. Luminal iota toxin induced fluid accumulation in the small intestine in a dose 33 
dependent manner, as determined by the enteropooling and the intestinal loop assays. None 34 
of these changes were observed in the large intestine. These results suggest that C. 35 
perfringens iota toxin alters intestinal permeability, predominantly by inducing necrosis 36 
and degenerative changes in the mucosal epithelium of the small intestine, as well as 37 
changes in intestinal motility. The obtained results suggest a central role for iota toxin in 38 
the pathogenesis of C. perfringens type E hemorrhagic enteritis, and contribute to remark 39 
the importance of clostridial binary toxins in digestive diseases. 40 
 41 
 42 
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 48 
1. Introduction 49 
 50 
Clostridium perfringens type E infection in domestic animals was first reported in the late 51 
1940s [1]. C. perfringens type E has been described to produce hemorrhagic enteritis in 52 
calves [2,3], cows [4], sheep [5] and goats [6]. Although these infections have generally 53 
been considered a rare occurrence in ruminants, there are numerous reports suggesting that 54 
type E isolates may account for approximately 5% of all C. perfringens isolates and that 55 
could be also associated with 50% of fatal hemorrhagic enteritis in calves [3,7]. In rabbits, 56 
like C. spiroforme infection [8], C. perfringens type E disease has been clinically 57 
characterized by general loss of condition, diarrhea and characteristic hemorrhagic lesions 58 
of the cecal serosa and mucosa, and eventually the distal ileum and proximal colon with 59 
presence of watery mucoid content [8]. As C. perfringens type E strains are defined by the 60 
production of iota toxin (ITX) [5], it is usually assumed that associated diseases are 61 
mediated by ITX, although no definitive evidence in this regard has been provided. ITX 62 
belongs to the family of binary actin ADP-ribosylating toxins [9]. Other members of this 63 
toxin family are C. difficile transferase (CDT), C. spiroforme transferase (CST), C. 64 
botulinum C2 toxin, and Bacillus cereus/sphaericus vegetative insecticidal proteins (VIP) 65 
[10]. These actin ADP-ribosylating binary toxins are composed of two unlinked proteins, 66 
an enzymatic component with ADP-ribosyltransferase activity and a binding component 67 
which binds to the cell surface receptor [11,12] and facilitates the enzymatic component 68 
entry to the cytosol [9]. 69 
Although cellular intoxication by ITX and binary toxins has been extensively studied 70 
[9,11–13], information about intestinal alterations induced by ITX are scant and usually 71 
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limited to descriptions of natural cases of type E diseases [3,4,6]. Therefore, the current 72 
work aims to examine the intestinal effects of ITX and to define the role of ITX in C. 73 
perfringens type E infection, revealing new insights into C. perfringens type E enteritis 74 
pathogenesis. Also, the results from this study suggest that the mouse is a useful animal 75 
model to study type E and ITX pathogenesis in vivo. 76 
 77 
 78 
2. Materials and Methods. 79 
 80 
2.1. Animals: 81 
Conventionally reared 20–25 g NHI Swiss outbred male mice were used. Animals were 82 
housed in a light cycle, humidity and temperature controlled room. Studies presented here 83 
were reviewed and approved by the institutional animal care and use committee (IACUC) 84 
from the CICVyA-INTA, protocol 32/2011. 85 
 86 
2.2. Iota toxin:  87 
Iota toxin (ITX) was purified from a type E culture as described by Stiles [14]. The purity 88 
of ITX was >95% as assessed by densitometry on 12% SDS/PAGE followed by Coomassie 89 
Blue staining. Activity and synergistic effect of Ia and Ib were tested on Caco-2 cell 90 
monolayers [15]. For in vivo assays, ITX concentration was expressed based on the activity 91 
on cell monolayers as ITX units (U), which are defined as the reciprocal of the highest 92 
dilution inducing cytopathic changes on cell monolayers. According to total protein 93 
concentration and the results of cell cytotoxicity tests, it was possible to determine that 200 94 
U/ml of ITX corresponded to a concentration of 1 µg/ml of Ia and 2 µg/ml of Ib. 95 
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 96 
2.3. Lethality of ITX in mice:  97 
The intragastric (i. g.) or intravenous (i. v.) lethality of ITX was determined using groups of 98 
4 mice each. Animals received two-fold dilutions of ITX in 1% peptone water. Before i. g. 99 
challenge, mice were fasted overnight but allowed access to water until 2 h before the start 100 
of the experiment. Groups of mice were inoculated by i. g. gavage with 0.5 ml of 1.5% PBS 101 
NaHCO3 containing purified ITX (50, 100, or 200 U/ml) or buffer solution without ITX. 102 
Another set of mice were i. v. injected with a total volume of 0.5 ml of PBS containing 103 
purified ITX (50, 100, or 200 U/ml) or buffer solution without ITX. All mice were 104 
observed for up to 72 h to monitor lethality, which was defined as death or development of 105 
significant respiratory or neurological signs. Mice showing significant respiratory or 106 
neurological signs were immediately euthanized and included in lethal dosed fifty 107 
(LD50/ml) calculations [16]. 108 
 109 
2.4. Effects of ITX on mice intestinal loops. 110 
2.4.1. Mice intestinal loop test: Mice were fasted during 18 h and deprived of water 2 h 111 
before the experiments. Anesthesia was then induced by intraperitoneal (i. p.) injection of 112 
100 mg/kg of ketamine and 5 mg/kg of diazepam. The abdomen of each mouse was 113 
disinfected with povidone-iodine solution (Pervinox) immediately before surgery. A 114 
midline laparotomy was performed, and the ileum or colon was exposed. Only one 2 cm 115 
long intestinal loop was prepared in the ileum or the colon of each animal by a double 116 
ligation. Care was taken to avoid overdistension of bowel loops and interference with the 117 
blood supply, eliminating a possible ischemic component to the toxin-induced damage. 118 
During surgery, the serosal surface of the loops was kept wet by frequent soaking with 119 
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normal saline solution. After injecting the inoculum, the abdominal incision was closed by 120 
separate muscle and skin sutures. The surgical procedure lasted approximately 3 min per 121 
animal. Mice were kept under anesthesia by periodic administration of ketamine-diazepam 122 
mix until the end of the experiments, 4 h after inoculation, and euthanized by cervical 123 
dislocation. 124 
2.4.2. Inoculum: In all experiments, a 0.5 ml aliquot of a Ringer’s solution containing 125 
specified amounts of purified ITX was injected into each intestinal loop. For the dose-126 
response experiments a mixture containing Ringer’s solution with 0, 100 or 200 U/ml of 127 
purified ITX was injected into each loop. . Additional loops received an injection of 128 
Ringer’s solution containing 200 U/ml of purified ITX that had been pre-incubated for 30 129 
min at room temperature with neutralizing mice anti-ITX polyclonal antibody or with anti-130 
ITX IgY [17]. The amount of both anti-ITX antibodies (mice and egg yolk) used was the 131 
minimum amount that neutralize ITX cytopathic changes on Caco-2 cell monolayers. 132 
Control loops were injected with ITX pre-incubated with antibodies obtained from pre-133 
immune sera of mice or laying hens. 134 
2.4.3. Histological analyses: At the end of the experiments, intestinal loops were excised 135 
and fixed by immersion in 10 % neutral buffered formalin at pH 7.2 for a minimum of 48 h, 136 
after which they were dehydrated through graded alcohols to xylene and embedded in 137 
paraffin wax. Samples were cut to obtain 4 µm thick sections. Tissue sections were 138 
prepared and stained either with hematoxylin and eosin (H/E) or used for 139 
immunohistochemistry (IHC) and examined by optical microscopy. 140 
2.4.4. ITX immunohistochemistry: Deparaffinized tissue sections were treated with 1% 141 
hydrogen peroxide in methanol to block endogenous peroxidases, followed by heat-induced 142 
antigen retrieval in 0.01 M citrate acid buffer (pH 6). After that, sections of intestines were 143 
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overlaid sequentially with an egg yolk polyclonal anti-ITX antibody (1/100, vol/vol), and 144 
peroxidase labeled rabbit anti-egg yolk (1/100, vol/vol; Sigma Aldrich Co) for 1 h each. 145 
Antibodies were diluted in PBS. Control sections were treated using the same buffer but 146 
omitting the primary antibody. Finally, preparations were revealed with diaminobenzidine 147 
and hydrogen peroxide solution (DAB cod K3468; DAKO) and observed by optical 148 
microscopy. 149 
 150 
2.5. Effects of ITX on intraluminal fluid accumulation:  151 
2.5.1. Enteropooling: Mucosal transport of fluid was determined using the enteropooling 152 
assay that evaluates the net accumulation of fluid in the lumen of the small intestine [19]. 153 
After 18 h of fasting and 2 h of water deprivation, mice were treated as follows. Groups of 154 
6 mice were dosed i. g. with 0.2 ml of 200 U/ml of ITX in 1.5% PBS NaHCO3 or buffer 155 
solution without ITX. Mice in both groups were sacrificed 4 or 20 h later. The small 156 
intestine of all mice was clamped at the pyloric sphincter and immediately before the 157 
ileocaecal junction, and carefully removed from the abdomen. The small intestine length 158 
(L) was measured and then weighed (W1), dried of fluid and reweighed (W2). The 159 
difference between W1 and W2 divided by the length [(W1-W2)/L] represents the 160 
“enteropooling” in milligrams of fluid per centimeter of intestine, which is an indication of 161 
intestinal fluid accumulation [18]. 162 
2.5.2. Fluid accumulation in intestinal loops: Mice intestinal loops in ileum and colon 163 
were prepared as previously described (Section 2.4.1.). Purified ITX (200 and 100U/ml in 164 
Ringer’s solution) or control (Ringer’s solution without ITX) was injected into each loop. 165 
After inoculation, the incisions in the peritoneum, abdominal muscles and skin were closed. 166 
Mice were kept under anesthesia by periodic administration of ketamine-diazepam mix 167 
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until the end of the experiments 4 h after inoculation, when they were killed by cervical 168 
dislocation. Intestinal loops were excised and the weight and length of each loop was 169 
measured. The net increase in the weight of the loop (in milligrams) was calculated as a 170 
relation between the weight of the inoculated loop and the length (in centimeters) of the 171 
loop [18]. 172 
 173 
2.6. Effects of ITX on gastrointestinal transit:  174 
The animals were deprived of food for 18 h prior to gastrointestinal transit measurement 175 
but allowed water ad libitum until 2 h before the experiments. Groups of 6 mice were dosed 176 
i. g. with 0.2 ml of 200 U/ml of ITX in 1.5% PBS NaHCO3 or 0.2 ml of buffer solution 177 
without ITX. A charcoal meal (0.2 ml per mouse) containing a solution of 1.5% arabic gum 178 
and 5% charcoal as a marker was given i. g. to conscious mice in ITX treated and control 179 
groups. Thirty minutes later, the mice were euthanized by cervical dislocation. The 180 
abdominal cavity was opened and the gastrointestinal tract was removed. The traveled 181 
distance of the marker was measured and expressed as a percentage of the total length of 182 
the small intestine from the pylorus to caecum and this percentage was used as a 183 
measurement of gastrointestinal transit [19]. 184 
 185 
2.7. Statistical analysis:  186 
A Bayesian approach was used [20]. For each of the measured variables, we tested the 187 
effect of treatment through stepwise model selection, from the simplest model to more 188 
complex ones using the information index Deviance Information Criterion (DIC) as an 189 
acceptance/reject rule for the proposed models, if a proposed model had lower DIC than the 190 
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currently accepted model, it was accepted, otherwise it was rejected. The procedure was 191 
repeated until the DIC began to increase. 192 
 193 
2.7.1. Proposed models for Enteropooling and Motility: 194 
Step 1:  195 
Null model: composed only of mean and error, in which the mean and error were assumed 196 
constant for all the individuals used and treatments applied, analogous to the null 197 
hypothesis in frequentist statistical approach. Two parameters. 198 
Step 2:  199 
Time Effect: The motility changed with time. Four parameters.  200 
ITX Treatment Effect: The response variable changed with the addition of ITX. Three 201 
parameters. 202 
Step 3 (proposed in case of acceptance of Step 2 models): 203 
Time + ITX Effect: Additive effect of both treatments. Five parameters. 204 
Step 4 (proposed in case of acceptance of Step 3 models): 205 
Time + ITX Effect plus interaction term: Additive effect of both treatments plus a 206 
multiplicative interaction term. Six parameters. 207 
2.7.2. Proposed models for loops: 208 
Step 1: 209 
Null Model: Similar to the previous one. Two parameters. 210 
Step 2: 211 
Treatment effect: The response variable changed with the addition of the treatment, 212 
independently of the concentration. Three parameters. 213 
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Treatment effect 2: The response variable changed with the addition of the treatment, and 214 
with different concentration. Four parameters. 215 
Linear Treatment effect: The response variable changed as a linear function of the 216 
concentration of the treatment. Three parameters. 217 
2.7.3. Fitting:  218 
In the case of Motility the variable measured was a proportion, so the data was logit-219 
transformed in order to use a normal-likelihood function to fit the models. For 220 
enteropooling and loops we used directly a normal likelihood function. Normal distribution 221 
with mean zero and ten standard deviation was used as an uninformative prior distribution 222 
for all the estimated parameters. A posteriori distribution of the parameters and the DIC 223 
index were calculated using the PyMC Markov-Chain Monte Carlo (MCMC) toolkit for the 224 
Python programming language [21]. Models were run for 200 000 iterations with a 100 000 225 
iteration discarded as a burn-in period and the second 100 000 were used to calculate the 226 
posterior distribution of parameters. We evaluated model convergence using Geweke's 227 
method. 228 
 229 
 230 
3. Results. 231 
 232 
3.1. ITX induces lethality in mice:  233 
Mice were i. g.  or i. v. challenged with 200 U, 100 U or 50 U of ITX (1 µg/ml Ia + 2 µg/ml 234 
Ib, 0.5 µg/ml Ia + 1 µg/ml Ib, 0.25 µg/ml Ia + 0.5 µg/ml Ib, respectively). The proposed 235 
model for ITX effect with lower DIC was the Null Model (DIC = 43.02), whereas the other 236 
proposed models in the stepwise procedure had higher DIC values (time effect DIC = 237 
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43.22, and ITX Treatment Effect DIC = 45.03). Therefore, ITX i. g. administration did not 238 
produce significant changes in survival times or signs of illness in any of the concentrations 239 
tested. Intravenous administration of 100 U and 50 U of ITX did not produce significant 240 
changes in survival times or signs of illness. When mice were inoculated i. v. with 200 U of 241 
ITX, onset of clinical manifestations (respiratory distress and depression) occurred within 242 
the first 6 h. In this group, the average time from inoculation to assay end point was 30 ± 10 243 
h. The intravenous LD50 of the ITX was determined to be 1 µg/ml of Ia + 2 µg/ml of Ib per 244 
mouse. 245 
 246 
3.2. Gross pathology and histological analysis:  247 
ITX treated ileal loops showed grossly red mucosa with thick, mucoid and red content, all 248 
of which could be observed from the serosal surface. The intestinal wall appeared thin and 249 
lost natural tone. A relatively low fluid accumulation was observed and the intestinal fluid 250 
became progressively bloodier as the ITX doses increased. Histological examination 251 
revealed that a 4 h treatment with ITX caused clear damage to mucosal epithelium and the 252 
severity and extent of this ITX-induced damage showed a dose dependency in ileal loops. 253 
Treatment of loops with 200 U/ml of ITX resulted in a severe necrosis of the intestinal 254 
epithelium with blunting and fusion of intestinal villi, extensive pseudomembrane 255 
formation with polymorphonuclear infiltration in the lumen and mucosa (Fig.1). 256 
Morphologic changes in loops treated with 100 U/ml of ITX include mild shortening of the 257 
villi with degenerative changes in enterocytes on the tip and center of the villi. Mild 258 
polymorphonuclear infiltrate and edema was also observed in the lamina propria and 259 
submucosa (Fig.1). These changes were not observed in the control ileal loops (Fig.1) or in 260 
loops exposed to purified ITX pre-incubated with one of two different neutralizing anti-ITX 261 
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antibodies, which totally abolished the ability of ITX to cause histological damage (data not 262 
shown).  These results show that ITX was the active agent producing the intestinal damage 263 
described above. In contrast, no histologic damage was observed when the colon was 264 
treated with ITX (100 or 200 U/ml). After 4 h of treatment with ITX, the colon appeared 265 
similar to the control colon treated only with Ringer’s solution. Together, these results 266 
indicated that purified ITX causes histologic damage in mouse small intestine but not in the 267 
colon, at least under the experimental conditions used in the present study. 268 
 269 
3.3. Intestinal ITX binding:  270 
ITX was injected into intestinal loops of mice and toxin binding was analyzed by indirect 271 
IHC. In ITX treated ileal loops, it was possible to observe extensive binding of toxin 272 
throughout the entire mucosa. Specific binding to mucosal epithelial cells was limited to the 273 
brush border; the cytoplasm and nuclei of labeled cells were unstained (Fig.2). Brush 274 
border binding was differentiable from any edge effect because individual cells exhibited 275 
intense staining while rare cells in the midst of positively stained cells were negative. 276 
Binding was observed at the tip, center and base of the villi. Crypt cells were also stained, 277 
but binding in the crypts was moderate compared with villi. No staining was detected in 278 
any ileum control loop (Fig.2) or colon loops, either treated or control. 279 
 280 
3.4. Effects of ITX on intestinal fluid accumulation:  281 
The effects of ITX in the fluid homeostasis of the intestine were initially determined by the 282 
enteropooling assay in mice. After i. g. challenge with 200 U/ml of purified ITX, no 283 
significant differences were observed when compared to the control group at 6 h (6.14 vs. 284 
6.92 mg/cm) and 20 h (9.78 vs. 9.72 mg/cm). The effects of ITX on intestinal fluid 285 
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accumulation were also evaluated in ligated ileal loops with 200 and 100 U/ml of purified 286 
ITX. Of the proposed models for loops, the lower DIC value was corresponding to Linear 287 
treatment effect (DIC = 52.73), whereas the other proposed models had higher DIC (Null 288 
Model, DIC = 53.54, Treatment Effect DIC = 54.12, Treatment Effect 2 DIC = 54.62). 289 
Therefore we found that increased fluid accumulation was observed in ITX treated loops, 290 
and it was linearly dependent on toxin concentration (Fig.3), with a slope of 0.016 +/- 0.01, 291 
and the intercept 0.77 +/- 0.516. Intestinal fluid accumulation was increased by 3 and 5-fold 292 
respect to control intestines after 4 h of treatment with 100 U and 200 U ITX, respectively. 293 
 294 
3.5. Effect of ITX on gastrointestinal transit:  295 
The charcoal meal method was used to test if i. g. delivered ITX inhibits intestinal motility. 296 
Administration of 200 U/ml of ITX had no effect on the luminal movement of the marker 297 
(charcoal), expressed as a percentage of the total length of the small intestine from the 298 
pylorus to caecum, when compared with the control group (data not shown). 299 
 300 
 301 
4. Discussion 302 
 303 
Iota toxin and infection by C. perfringens type E strains are associated with sudden death 304 
and hemorrhagic enteritis in different animal species [2–5]. Although ITX production is 305 
limited to type E strains, structurally related binary toxins are widely spread among other 306 
species of enterotoxic clostridia and Bacillus [22]. Based on sequence homology, 307 
immunological cross-reactivity and biologically active chimeras formation, clostridial 308 
binary toxins are classified in two families, the iota family and the C2 family [23]. Besides 309 
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ITX, the iota-family also includes C. difficile CDT and C. spiroforme CST [23]. These 310 
toxins not only share structure and sequence homology but might also share biological 311 
functions such as the observed strain specific increase of intestinal attachment of C. 312 
perfringens bacterial cells [17] in other clostridial species including C. difficile [24].    313 
Although cellular intoxication by ITX and binary toxins has been extensively studied 314 
[9,11–13], there is scant information about intestinal alterations induced by binary toxins 315 
and their role in digestive diseases, usually limited to descriptions of natural cases [2–4,25]. 316 
In the present report, mice were used as animal model to study the effects of ITX in the 317 
gastrointestinal tract. According to previous studies, mice are sensitive to ITX [26] and 318 
provide several advantages over other species as model given its small size and wide 319 
availability [27–29]. The LD50 for i. v. ITX was in agreement with previous reports [14,30], 320 
which is a relatively high LD50 (above 1 µg/mouse) compared to other toxins that produce 321 
enterotoxemia (i.e. epsilon toxin, 3 ng/mouse), raising questions about the role of ITX in 322 
clinical signs and systemic changes described in natural cases of type E disease, usually 323 
defined as type E or iota enterotoxemia [3]. 324 
Several reports of disease associated with C. perfringens type E in cattle show that the 325 
dominant necropsy finding is hemorrhagic enteritis affecting jejunum and ileum [3,4], and 326 
severe necrosis of the mucosal epithelium as the main microscopic lesions of the small 327 
intestine. The histopathological findings of the present study are consistent with those 328 
described in natural cases of cattle type E enteritis [3,4]. Intraintestinal inoculation of 329 
purified ITX in ileal ligated loops of mice reproduced microscopic changes in a dose-330 
dependent manner, which could be prevented using anti-ITX neutralizing antibodies.                                                                                                                                          331 
The development of progressive microscopic lesions with increasing ITX concentrations 332 
provides new insights into the pathogenesis of type E diseases. First, treatment of ligated 333 
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ileal loop with a low toxin concentration causes necrosis of enterocytes at the tip of the villi 334 
and degenerative changes in the enterocytes of the middle region of the villi. These 335 
conditions may represent those present at the onset of the disease, where the first cells to be 336 
affected seem to be enterocytes of the tip of the villus. With a higher concentration of toxin, 337 
it is possible to observe mucosa areas with completely detached epithelium, wich can also 338 
be considered as a progression of the action of lower concentrations of toxin. Also, 339 
coincident with reports of type E disease in ruminants, mice challenged with ITX did not 340 
develop alterations in the large intestine after intragastric and colonic loops challenge. 341 
Although C. perfringens type E infection is generally associated with sudden death, some 342 
reports describe the occurrence of diarrhea in cattle [3,6].  Previous in-vitro and in-vivo 343 
studies suggest that ITX can have a key role in alterations of intestinal fluid homeostasis. 344 
In-vitro studies show that ITX can induce permeability changes in Caco-2 cells monolayers 345 
[15]. In-vivo studies with other clostridial binary toxins, like CDT from C. difficile [31,32] 346 
and BEC from C. perfringens [33,34], also described fluid accumulation in the intestinal 347 
lumen. In the present report, fluid imbalance was determined by two different approaches, 348 
enteropooling and intestinal loops. Although the enteropooling technique estimates the net 349 
movement of fluid through the intestinal wall [18], the differences influid accumulated in 350 
the small intestine after treatment with ITX were not statistically significant. . It was 351 
possible to observe a statistically significant increase in liquid accumulation in a dose 352 
dependent manner when ligated ileal loops were used. These results suggest an enterotoxic 353 
action of ITX and reinforce the concept that binary toxins could share biological effects. 354 
For example, as while C. difficile infection in most species is considered a large bowel 355 
disease, strains producing only CDT induce fluid accumulation in ileum as it was observed 356 
using different animal models like rabbit [32] or golden hamster [31].   357 
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Histopathology analysis of treated loops showed that ITX causes degenerative changes and 358 
necrosis of small intestinal enterocytes, suggesting that fluid accumulation could be 359 
associated with loss of intestinal epithelial barrier integrity. Apical and lateral region of the 360 
villi were the most affected areas, and a functional decrease of these enterocytes, which are 361 
primarily responsible for the absorption of water, would lead to a net increase in the amount 362 
of liquid present in the intestinal lumen. Higher concentrations of ITX induce epithelium 363 
detachment with the concomitant fluid passage from blood and lymph to intestinal lumen. 364 
Since gastrointestinal motility disturbances is animportant mechanism involved in digestive 365 
disorders, ITX effect upon intestinal motility was measured by intestinal dye retention, a 366 
method widely used in different studies [19]. No differences were observed between ITX 367 
treated animals and controls, suggesting that ITX has no effect on gastrointestinal motility. 368 
However, further studies with different approaches would be  necessary to confirm this 369 
result.  370 
 The present study shows that ITX produces intestinal damage consistent with lesions 371 
observed in natural cases of type E enteritis. Therefore, it is possible to propose a central 372 
role for ITX in C. perfringens type E pathogenesis and probably for other binary toxins in 373 
determined diseases like CDT in C. difficile enteritis and, eventually, colitis. According to 374 
our findings, changes in mucosal epithelium could be one of the main mechanisms 375 
involved in type E pathogenesis. The current study serves as a starting point to propose 376 
potential mechanisms involved in initial stages of C. perfringens type E pathogenesis. 377 
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Figure legends 501 
Fig 1: Histology of ITX treated small intestine loops. After 4 h of treatment, loop tissues 502 
were formalin fixed and embedded in paraffin. H/E was used to stain 4 um-thick sections of 503 
intestinal tissue. Control loops (A). Loops treated with 100 U/ml (B) and 200 U/ml (C) of 504 
purified ITX. Scale bar, 100 µm.  505 
Fig 2: Immunohistochemistry of ITX treated small intestine. (A) Sections of intestinal 506 
tissue treated with control buffer. (B) Sections of intestinal tissue treated with 100 U/ml of 507 
purified ITX. In ITX treated loops the brush border is variably labeled with dense staining 508 
of individual cells adjacent to cells not stained (arrows). Scale bar, 20 µm. 509 
Fig 3: ITX alters fluid homeostasis in the small intestine. Ligated ileal segments (loops) 510 
were excised 4 hours after injection of ITX and intestinal water was determined. Data 511 
shown are mean values obtained by using 4 mice (1 ileal loop/mouse). Error bars represent 512 
the SEM. Results are expressed as means ±SEM based on data from 4 loops for each ITX 513 
dose. 514 
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Highlights: 
 
1. Iota toxin intestinal effects were evaluated in a mouse model. 
2. Iota toxin causes histological damage in mouse ileal loops. 
3. Luminal iota toxin induced fluid accumulation in the small intestine. 
4. Mice are sensitive to intravenously administered iota toxin. 
